基于纳米技术的先进核酸药物
Noriko Miyamoto1,2, Mina Sakuragi3, Yukio Kitade1,2,4
1Department of Applied Chemistry, Faculty of Engineering, Aichi Institute of Technology, 1247 Yachigusa, Yakusa-cho, Toyota 470-0392, Japan.
Pharmaceutics
|November 27, 2024
概括
核酸药物看起来很有前途,但面临着交付挑战. 纳米技术提供了解决方案,许多基于纳米技术的核酸药物在全球和日本的临床试验中.
科学领域:
- 生物技术和制药科学 生物技术和制药科学
- 纳米医学是一种纳米医学.
- 分子治疗学分子治疗学
背景情况:
- 核酸药物提供序列特定的向分子.
- 美国食品和药物管理局批准了21种核酸药物.
- 在组织向和细胞内传递方面仍然存在挑战.
研究的目的:
- 审查用于核酸药物的纳米技术的最新进展.
- 总结日本基于纳米技术的核酸药物的临床试验的现状.
- 讨论这种治疗方式的未来期望.
主要方法:
- 关于纳米技术应用于核酸药物的最新研究的文献综述.
- 对基于纳米技术的核酸药物的临床试验数据的分析,重点是日本.
- 综合目前的趋势和未来的前景.
主要成果:
- 超过40种基于纳米技术的核酸药物已经进入日本以外的临床试验,目前有15种活跃.
- 目前,日本正在进行三项I期临床试验,涉及基于纳米技术的核酸药物.
- 纳米技术正在积极使用,以克服交付和准挑战.
结论:
- 纳米技术对于推动核酸药物开发至关重要.
- 日本的临床试验正在进行中,预计会有结果.
- 预计纳米技术在核酸药物中的进一步发展.
关键词:
在ASO的基础上,ASO是ASO.在CpG-ODNN中使用.它们是DNA DNA DNA DNA.药物输送系统是药物输送系统.脂质纳米颗粒的使用方法它们是mRNARNA.这是一个小RNARNA.纳米技术是纳米技术.基于纳米技术的医学核酸药物 核酸药物我们的pDNApDNAsiRNA 是一个RNA.更多相关视频
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
9.4K
07:16Author Spotlight: Advancements in DNA Nanosensors – Addressing Sensitivity and Selectivity Challenges in Molecular Detection
Published on: February 9, 2024
890
相关概念视频
Microorganisms in Medicine and Therapeutics
1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
